BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2107257)

  • 21. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
    Bobak DA; Gaither TA; Frank MM; Tenner AJ
    J Immunol; 1987 Feb; 138(4):1150-6. PubMed ID: 3492544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
    Schultz RM; Nanda SK; Altom MG
    J Immunol; 1985 Sep; 135(3):2040-4. PubMed ID: 2991375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function.
    Hamilton TA; Jansen MM; Somers SD; Adams DO
    J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: LPS, immune complexes, and zymosan alone and in combination with interferon-gamma.
    Zhou AQ; Herriott MJ; Leu RW
    J Leukoc Biol; 1991 Nov; 50(5):453-63. PubMed ID: 1748841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
    Lambert LE; Paulnock DM
    J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthermic modulation of respiratory inhibition factor- and iron releasing factor-dependent macrophage murine tumor cytotoxicity.
    Klostergaard J; Barta M; Tomasovic SP
    Cancer Res; 1989 Nov; 49(22):6252-7. PubMed ID: 2680061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
    Hori K; Ehrke MJ; Mace K; Mihich E
    Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C inhibitors block the activation of macrophages by IFN-beta but not by IFN-gamma.
    Radzioch D; Varesio L
    J Immunol; 1988 Feb; 140(4):1259-63. PubMed ID: 3125252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The in vitro effect of silica fibers on macrophage-mediated cytotoxic activities in mice].
    Yin L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):287-92. PubMed ID: 2558812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
    Leu RW; Rummage JA; Horn MJ
    Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
    J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits.
    Müller W; Hanauske-Abel H; Loos M
    J Immunol; 1978 Oct; 121(4):1578-84. PubMed ID: 701808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation.
    Jiang H; Stewart CA; Tan SY; Fast DJ; Rummage JA; Leu RW
    Cell Immunol; 1996 Feb; 167(2):293-301. PubMed ID: 8603439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.